Point72 (DIFC)’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,839	Closed	-$25.4K	–	1530
2025 Q1	$25.4K	Buy	+2,839	New	+$25.4K	﹤0.01%	652
2024 Q3	–	Sell	-1,824	Closed	-$15.5K	–	1386
2024 Q2	$15.5K	Buy	+1,824	New	+$15.5K	﹤0.01%	728